Tradestie Institutional Equity Comparison Engine

THW vs HQL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HQL Overall Edge

HQL Captures Institutional Edge (1โ€“0 Pillars ยท 1โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to abrdn Life Sciences Investors (HQL) driven by superior Momentum & Technical. Fundamentally, THW trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus HQL at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, THW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against HQL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
THW N/M vs HQL N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner HQL
1Y +2.0% vs +6.2% ยท 52W Pos 51% vs 31%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
THW NYSE
abrdn World Healthcare Fund
Institutional Equity
$12.88
-1.98% 1D
Market Cap $510.6M
1M Return +6.53%
1Y Return +2.02%
Forward P/E N/M
Unified AI Score
36.7 / 100 SELL
Tech 34.0 Fund 42.0 Flow 50.0 Mom 50.0
HQL NYSE
abrdn Life Sciences Investors
Institutional Equity
$17.81
-2.57% 1D
Market Cap $455.0M
1M Return +6.14%
1Y Return +6.2%
Forward P/E N/M
Unified AI Score
46.0 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: THW +2.02% HQL +6.2% Spread: +4.18 pp (HQL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
THW TTM Op. Margin: N/A HQL TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on THW vs HQL. Trailing 12-month operating profitability (THW N/A vs HQL N/A) and valuation multiples (THW N/M vs HQL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: THW (3) vs HQL (1)
Institutional Metric THW HQL Criterion Row Winner
Market Capitalization Scale $510.6M $455.0M Larger Scale THW
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 51% ($11โ€“$14) 31% ($16โ€“$23) Stronger Trend THW
Beta / 30D Volatility Risk Regime 0.71ฮฒ ยท 27% Vol 0.91ฮฒ ยท 39% Vol Lower Realized Risk THW
Unified Institutional Score Composite Signal 36.7 / 100 (SELL) 46.0 / 100 (HOLD) Higher Composite HQL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full THW vs HQL Buy Guide
THW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live THW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
HQL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live HQL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither THW nor HQL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.